Ts. Trovik et al., REDUCED BETA-ADRENERGIC SENSITIVITY IN HEALTHY-VOLUNTEERS INDUCED BY HYPOGLYCEMIA, Fundamental and clinical pharmacology, 9(2), 1995, pp. 181-186
A single causative mechanism for development of hypoglycemia unawarene
ss in insulin-dependent diabetes mellitus IDDM) is not yet apparent. R
educed adrenergic sensitivity may be part of the explanation. This stu
dy was carried out to investigate the effect of hypoglycemia on beta-a
drenergic sensitivity. Ten healthy male subjects (age 19-23 years) gav
e informed consent to take part in the study. They were hospitalized o
vernight at the University Hospital of Tromso Department of Clinical R
esearch, on two occasions. Isoprenaline and metoprolol sensitivity tes
ts were performed the morning after hospitalization: once after an int
ravenous (iv) injection of placebo (0.9% NaCl), and once after an iv i
njection of insulin (0.15 IU insulin/kg body weight) to induce hypogly
cemia. The dose of isoprenaline needed to increase heart rate (HR) by
25 beats per minute (bpm) (I-25), and the dose of metoprolol (M(-12.5)
) needed to inhibit I-25 with 50% or 12.5 bpm, when injected simultane
ously, were used as determinants of isoprenaline and metoprolol sensit
ivity. In this study, there was a significant (p < 0.05) increase both
in I-25 and M(-12.5) after hypoglycemia. The dose-response curve of i
soprenaline/HR was significantly shifted to the right after hypoglycem
ia. This study shows that acute hypoglycemia induces a reduction in be
ta-adrenegic sensitivity, and it supports the hypothesis of reduced be
ta-adrenergic sensitivity as an important pathophysiological mechanism
in hypoglycemia unawareness in IDDM.